Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., & de Haes, J. C. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. https://doi.org/10.1093/jnci/85.5.365

Article  PubMed  CAS  Google Scholar 

Cocks, K., King, M. T., Velikova, G., de Castro, G. J., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2012). Evidence-based guidelines for interpreting change scores for the European organisation for the research and treatment of cancer quality of life questionnaire core 30. European Journal of Cancer (Oxford, England: 1990), 48(11), 1713–1721.

PubMed  CAS  Google Scholar 

Cocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 29(1), 89–96. https://doi.org/10.1200/JCO.2010.28.0107

Article  PubMed  Google Scholar 

Coomans, M. B., Dirven, L., Aaronson, N., Baumert, B. G., Bent, M. Van Den, Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-guibert, F., Malmström, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., & Taphoorn, M. J. B. (2022). Neuro-Oncology Factors associated with health-related quality of life ( HRQoL ) deterioration in glioma patients during the. 24(April), 2159–2169.

Coomans, M. B., Taphoorn, M. J. B., Aaronson, N. K., Baumert, B. G., van den Bent, M., Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmström, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., & Dirven, L. (2020). Measuring change in health-related quality of life: The impact of different analytical methods on the interpretation of treatment effects in glioma patients. Neuro-Oncology Practice, 7(6), 668–675. https://doi.org/10.1093/nop/npaa033

Article  PubMed  PubMed Central  Google Scholar 

Dirven, L., Musoro, J. Z., Coens, C., Reijneveld, J. C., Taphoorn, M. J. B., Boele, F. W., Groenvold, M., van den Bent, M. J., Stupp, R., Velikova, G., Cocks, K., Sprangers, M. A. G., King, M. T., Flechtner, H.-H., & Bottomley, A. (2021). Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-Oncology, 23(8), 1327–1336. https://doi.org/10.1093/neuonc/noab037

Article  PubMed  PubMed Central  Google Scholar 

Dirven, L., Vos, M. E., Walbert, T., Armstrong, T. S., Arons, D., van den Bent, M. J., Blakeley, J., Brown, P. D., Bulbeck, H., Chang, S. M., Coens, C., Gilbert, M. R., Grant, R., Jalali, R., Leach, D., Leeper, H., Mendoza, T., Nayak, L., Oliver, K., & Taphoorn, M. J. B. (2021). Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the response assessment in neuro-oncology patient-reported outcome (RANO-PRO) initiative. Neuro-Oncology Practice, 8(4), 417–425. https://doi.org/10.1093/nop/npab013

Article  PubMed  PubMed Central  Google Scholar 

Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, on behalf of the E. Q. of L. G. (2001). The EORTC QLQ-C30 Scoring Manual (3rd ed.). European Organisation for Research and Treatment of Cancer, Brussels.

Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clinic Proceedings, 77(4), 371–383. https://doi.org/10.4065/77.4.371

Article  PubMed  Google Scholar 

King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 5(6), 555–567. https://doi.org/10.1007/BF00439229

Article  PubMed  CAS  Google Scholar 

Koller, M., Musoro, J. Z., Tomaszewski, K., Coens, C., King, M. T., Sprangers, M. A. G., Groenvold, M., Cocks, K., Velikova, G., Flechtner, H.-H., & Bottomley, A. (2022). Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials. Lung Cancer (Amsterdam, Netherlands), 167, 65–72. https://doi.org/10.1016/j.lungcan.2022.03.018

Article  PubMed  CAS  Google Scholar 

Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathologica, 131(6), 803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Maringwa, J., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Reeve, B. B., Gotay, C., Greimel, E., Flechtner, H., Cleeland, C. S., Schmucker-Von Koch, J., Weis, J., Van Den Bent, M. J., Stupp, R., Taphoorn, M. J., & Bottomley, A. (2011). Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 22(9), 2107–2112. https://doi.org/10.1093/annonc/mdq726

Article  PubMed  CAS  Google Scholar 

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 16(1), 139–144. https://doi.org/10.1200/JCO.1998.16.1.139

Article  PubMed  CAS  Google Scholar 

Peeters, M. C. M., Zwinkels, H., Koekkoek, J. A. F., Vos, M. J., Dirven, L., & Taphoorn, M. J. B. (2020). The impact of the timing of health-related quality of life assessments on the actual results in glioma patients: A randomized prospective study. Cancers. https://doi.org/10.3390/cancers12082172

Article  PubMed  PubMed Central  Google Scholar 

Pinson, H., Silversmit, G., Vanhauwaert, D., Vanschoenbeek, K., Okito, J.-P.K., De Vleeschouwer, S., Boterberg, T., & De Gendt, C. (2024). Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era. Neuro-Oncology, 26(1), 191–202. https://doi.org/10.1093/neuonc/noad158

Article  PubMed  Google Scholar 

Salas Apaza, J. A., Franco, J. V. A., Meza, N., Madrid, E., Loézar, C., & Garegnani, L. (2021). Minimal clinically important difference: The basics. Medwave, 21(3), Article e8149. https://doi.org/10.5867/medwave.2021.03.8149

Article  PubMed  Google Scholar 

Schwarz, N. (1990). What respondents learn from scales: the informative functions of response alternatives*. International Journal of Public Opinion Research, 2(3), 274–285. https://doi.org/10.1093/ijpor/2.3.274

Article  Google Scholar 

Taphoorn, M. J. B., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., Stupp, R., Mirimanoff, R. O., van den Bent, M. J., & Bottomley, A. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer, 46(6), 1033–1040. https://doi.org/10.1016/j.ejca.2010.01.012

Article  PubMed  Google Scholar 

Tourangeau, R. (1984). Cognitive Sciences and Survey Methods. Cognitive Aspects of Survey Methodology : Building a Bridge Between Disciplines, November, 73–100. http://site.ebrary.com.ezproxy.lib.ucalgary.ca/lib/ucalgary/detail.action?docID=10495478

van den Bent, M. J., Geurts, M., French, P. J., Smits, M., Capper, D., Bromberg, J. E. C., & Chang, S. M. (2023). Primary brain tumours in adults. The Lancet, 402(10412), 1564–1579. https://doi.org/10.1016/S0140-6736(23)01054-1

Article  Google Scholar 

van der Meer, P. B., Habets, E. J. J., Wiggenraad, R. G., Verbeek-de Kanter, A., Lycklama À Nijeholt, G. J., Zwinkels, H., Klein, M., Dirven, L., & Taphoorn, M. J. B. (2018). Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy. Journal of Neuro-Oncology, 139(2), 359–368. https://doi.org/10.1007/s11060-018-2868-7

Article  PubMed  PubMed Central  Google Scholar